Spectral AI, Inc. (MDAI)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | - | 15 | 25 | 18 | 30 | 20 | 15 | 19 |
| Operating profit | $m | -9 | -12 | ||||||
| Net profit | $m | - | -4 | -3 | -21 | -15 | -8 | -10 | -12 |
| EPS reported | $ | -0.29 | -0.35 | ||||||
| Operating cashflow per share | $ | -0.37 | -0.40 | ||||||
| Capex per share | $ | 0.00 | 0.00 | ||||||
| FCF per share | $ | -0.37 | -0.40 | ||||||
| Free cash flow | $m | -10 | -13 | ||||||
| Net debt | $m | -6 | 1 | ||||||
| Book value equity | $m | -6 | -12 | ||||||
| Book value per share | $ | -0.22 | -0.38 | ||||||
| Number of shares | m | 26.52 | 32.08 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | -6.58 | -3.12 | ||||||
| P/S LTM | x | 1.92 | 2.48 | ||||||
| P/FCF LTM | x | -3.80 | -2.92 | ||||||
| EV/EBITDA LTM | x | -5.97 | -3.82 | ||||||
| EV/Sales LTM | x | 1.65 | 3.68 | ||||||
| Earnings Yield LTM | % | -20.11% | -19.48% | ||||||
| FCF Yield | % | -26.34% | -34.20% | ||||||
| Quality | |||||||||
| ROE | % | +132.20% | +120.69% | ||||||
| ROIC | % | -1.97% | -2.88% | ||||||
| Operating margin | % | -43.78% | -79.95% | ||||||
| Gross margin | % | +45.42% | +41.51% | ||||||
| FCF/Sales | % | -50.48% | -84.97% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -33.57% | -48.76% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -0.98 | -0.79 | ||||||
| Net Debt/EBITDA | x | 0.98 | -0.27 | ||||||
| EBIT/Net interest | x | -5.71 | -8.07 | ||||||
| Net debt/market cap | % | +24.86% | +30.41% | ||||||
| Net debt/Equity | x | 1.05 | -0.08 | ||||||
| Gross debt/equity | x | -1.76 | -1.35 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free